Suchergebnisse - "IL-6 antagonist"

PubPharm (15)

1

Review of Satralizumab for Neuromyelitis Optica Spectrum Disorder : A New Biologic Agent Targeting the Interleukin-6 Receptor

enthalten in: Cureus | 2024

von Meher, B. | Mohanty, R. | Dash, A.

2

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients : results from a real-world cohort

enthalten in: Infection | 2023

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

3

A Prospective Cohort Study of COVID-19 : Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Al Kharusi, M. | Al Sheikh, N. | Alhajri, M. | +5

4

A Prospective Cohort Study of COVID-19: Evaluation of the Early Role of IL-1 and IL-6 Antagonists in Improving the Outcome of the Illness and Reduction in the Risk of Death

in: Healthcare | 2023

von Mardheya Al. Kharusi | Naffesa Al Sheikh | Maiya Alhajri | +5

5

Rare presentation of multiple thromboses in Erdheim-Chester disease : a case-based review

enthalten in: International journal of hematology | 2022

von Liu, Y. | Huang, C. | Meng, X. | +4

6

Interleukin-6 Antagonists : Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection

enthalten in: Journal of pharmacy practice | 2022

von Meanwatthana, J. | Majam, T.

7

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort

enthalten in: Infection | 2022

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

8

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort

enthalten in: Infection | 2022

von Karolyi, M. | Gruebl, A. | Omid, S. | +14

9

Rare presentation of multiple thromboses in Erdheim–Chester disease: a case-based review

enthalten in: International journal of hematology | 2022

von Liu, Y. | Huang, C. | Meng, X. | +4

10

Rare presentation of multiple thromboses in Erdheim–Chester disease: a case-based review

enthalten in: International journal of hematology | 2022

von Liu, Y. | Huang, C. | Meng, X. | +4